Grover Davinder S, Fellman Ronald L
Glaucoma Associates of Texas, Dallas, TX.
J Glaucoma. 2017 Jul;26(7):633-637. doi: 10.1097/IJG.0000000000000686.
To report outcomes for a novel ab interno bleb revision technique and spatula.
This is a retrospective chart review.
A total of 21 eyes of 21 patients underwent ab interno bleb revision with the Grover-Fellman biplanar sclerostomy spatula. Mitomycin C was given at least 1 week preoperation. The mean age of the patients and blebs were 67 and 6.75 years, respectively. The mean follow-up is 10.6 months (range: 3 to 17 mo). Mean preoperative intraocular pressure (IOP) (SD) was 21.9 (9.1) mm Hg on 3.7 (1.2) glaucoma medications. At 12 months follow-up, the mean IOP was 12.1 mm Hg on 0.86 medications. Four eyes failed due to uncontrolled IOP needing a tube shunt. One eye failed due to uncontrolled IOP but was lost to follow-up before a tube shunt could be performed. All failures occurred within 3 months. Two eyes had an IOP of <5 mm Hg after 1 month with no evidence of hypotony maculopathy. These cases resolved after 3 months without surgical intervention. All successful cases had blebs that were low, diffuse, and posterior.
After a failed filtration surgery, a low-diffuse bleb was reestablished by pretreating with subconjunctival mitomycin C followed by ab interno bleb revision with the Grover-Fellman biplanar sclerostomy spatula, decreasing further more invasive glaucoma procedures.
报告一种新型经内路滤过泡修复技术及刮匙的治疗效果。
这是一项回顾性病历审查。
21例患者的21只眼接受了使用格罗弗 - 费尔曼双平面巩膜造瘘刮匙的经内路滤过泡修复术。丝裂霉素C在术前至少1周使用。患者及滤过泡的平均年龄分别为67岁和6.75岁。平均随访时间为10.6个月(范围:3至17个月)。术前平均眼压(IOP)(标准差)为21.9(9.1)mmHg,使用3.7(1.2)种青光眼药物。在12个月随访时,平均眼压为12.1 mmHg,使用0.86种药物。4只眼因眼压控制不佳需要行引流管植入术而失败。1只眼因眼压控制不佳失败,但在可行引流管植入术前失访。所有失败均发生在3个月内。2只眼在1个月后眼压<5 mmHg,无低眼压性黄斑病变证据。这些病例在3个月后未经手术干预自行缓解。所有成功病例的滤过泡均为低位、弥散且位于后方。
滤过性手术失败后,通过结膜下丝裂霉素C预处理,然后使用格罗弗 - 费尔曼双平面巩膜造瘘刮匙进行经内路滤过泡修复,可重建低位弥散滤过泡,减少进一步更具侵入性的青光眼手术。